£30.0M
The investment round was co-led by Sofinnova Partners and Redmile Group to fund global expansion and research programmes.
SF
Sphere Fluidics
Sphere Fluidics develops single cell analysis and characterisation systems for biopharmaceutical discovery.
£40.7MTotal raised
Sphere Fluidics develops single cell analysis and characterisation systems for the biopharmaceutical sector.
Categories
Team
Frank Craig
CEO
Frank chairs BioChannel Partners and previously served as chief executive of Sphere Fluidics and Life Sciences Consultancy.
LinkedInZN
Zoe Nilsson
Zoe brings marketing experience from bit.bio, Sphere Fluidics, and Axol Bioscience.
LinkedIn
Andrew Mackintosh
Chairman
Andrew serves as chairman of Sphere Fluidics and UKI2S, alongside board roles at Foresight Ventures VCT and ACF Investors. He also sits on advisory committees for Oxford University and the Government Office of Technology Transfer.
LinkedInMR
Marian Rehak
R&D Director
Marian brings extensive research and development experience, having previously led R&D teams at Sphere Fluidics Limited. He currently serves as Technical Director at Mast Group Ltd.
LinkedIn
Rob Marchmont
Commercial Director
Rob brings commercial experience in the life sciences sector, including a decade as commercial director at Sphere Fluidics and fractional roles at StemBond Technologies.
LinkedInInvestors
- £30.0M
- £3.7M
- $7.0M
Funding history
£3.7M
Greenwood Way Capital and 24Haymarket led the financing round to support international expansion and operations.
$7.0M
The investment round was led by an Asian corporate investor alongside existing backers to fund the commercial launch of Cyto-Mine.